Patents Assigned to SORBONNE UNIVERSITE
-
Publication number: 20250144181Abstract: A pharmaceutical compositions includes GLP-1 and GLP-1 analogues inducing an anabolic stimulation of chondrocytes and a decreasing in chondrocyte catabolic including a decrease in cartilage matrix loss and cartilage degeneration for use in the treatment of cartilage disease. The composition induces cartilage regeneration and anabolic stimulation of chondrocytes, including chondrocyte proliferation and/or stem cell differentiation into chondrocytes.Type: ApplicationFiled: January 10, 2025Publication date: May 8, 2025Applicants: 4MOVING BIOTECH, SORBONNE UNIVERSITEInventors: Francis BERENBAUM, Revital RATTENBACH
-
Patent number: 12281319Abstract: The disclosure is directed at providing molecular tools and methods for transgenes integration in the genome of host cells, in particular tools and method enabling a transposition-dependent expression of the transgene, thereby facilitating identification and selection of effectively transformed hosts.Type: GrantFiled: May 17, 2019Date of Patent: April 22, 2025Assignees: SORBONNE UNIVERSITE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Jean Livet, Takuma Kumamoto, Raphaëlle Barry-Martinet, Samuel Tozer, Franck Maurinot, Karine Loulier-Le Franc, Mickaël Le, Stéphane Nedelec, Michel Cohen-Tannoudji
-
Patent number: 12278571Abstract: The invention relates to a device forming a DC voltage bus for a polyphase electrical system (M), comprising voltage legs (A1, A2, A3) each having a plurality of battery cell modules (C1, C2, C3), each module comprising a battery cell or a cluster of battery cells (c1), connected to a DC-to-AC converter (DCAC); said battery cell modules (C1, C2, C3) being connected together in series via the DC-to-AC converter (DCAC); said voltage legs (A1, A2, A3) each being connected to a specific phase leg (B1, B2, B3) for said polyphase electrical system (M), at least one phase leg (B1, B2, B3) having a branch (D1, D2, D3) connected to a rectifier module (R1). The invention also relates to a motor vehicle, a renewable energy generator and a method based on such a system.Type: GrantFiled: March 16, 2022Date of Patent: April 15, 2025Assignees: PSA Automobile SA, Centrale Supelec, Centre National de la Recherche Scientifique, SAFT, Sorbonne Universite, Universite Paris-SaclayInventors: Francis Roy, Thomas Peuchant, David Herpe, Eric Laboure, Franck Castejon
-
Publication number: 20250115862Abstract: A technique for moving various objects such as cells and particles of hydrogel or a compressible material, suspended in a fluid, so as to form a layered structure akin to human organ tissue. A standing sound wave is propagated through the fluid so as to position the cells on a pressure node and the particles on a pressure antinode. As such, the cells have a positive acoustic contrast relative to the fluid, while the particles have a negative acoustic contrast relative to the fluid.Type: ApplicationFiled: September 27, 2022Publication date: April 10, 2025Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, SORBONNE UNIVERSITE, UNIVERSITE PARIS CITEInventors: Chloé DUPUIS, Jean-Luc AIDER, Jean-Michel PEYRIN, Mauricio HOYOS
-
Patent number: 12269000Abstract: The present invention relates to a method for producing a colloid comprising functionalised liquid colloidal particles. The invention also relates to such a colloid and to the uses thereof.Type: GrantFiled: May 24, 2019Date of Patent: April 8, 2025Assignees: Paris Sciences et Lettres, Centre National de la Recherche Scientifique (CNRS), Sorbonne UniversiteInventors: Jacques Fattaccioli, Lea Pinon, Lorraine Montel
-
Patent number: 12265012Abstract: The present invention relates to a device for determining the position of a plurality of objects that are simultaneously trapped by a single laser beam, characterized in that the device comprises:—a laser source for emitting a laser beam, an actuation system for a three-dimensional deflecting of the laser beam between several trapping points,—a microscope objective for focusing the laser beam coming from the actuation system on the trapping points,—a sample chamber including the objects to be trapped on the trapping points,—a light source for lighten the sample chamber, and—a camera for determining the position of each of the trapped objects, said camera being located between the laser source and the actuation system, so that the light emitted by the light source passes successively through the sample chamber, the microscope objective, the actuation system and the camera.Type: GrantFiled: October 29, 2020Date of Patent: April 1, 2025Assignees: Sorbonne Université, Centre National de la Recherche ScientifiqueInventors: Sinan Haliyo, Stéphane Régnier, Edison Gerena
-
Patent number: 12256992Abstract: Disclosed is a device including a detector producing a signal depending on variations of the pupil diameter of an eye of a subject, a display for presenting, to the subject, a light pattern subdivided into a plurality of regions, and an analyzer receiving the signal of the detector and analyzing the frequential content thereof. The display is controlled such that each region has a light intensity modulated at a respective modulation frequency, the modulation frequencies being different from one region to the next.Type: GrantFiled: July 16, 2019Date of Patent: March 25, 2025Assignees: SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)Inventors: Jean Lorenceau, Suzon Ajasse
-
Patent number: 12251451Abstract: The present description relates to an injectable emulsion comprising an amphiphilic compound, a first phase comprising droplets including at least one perfluorocarbon compound and a second phase, which is aqueous. The droplets have a diameter d4,3 of between 0.5 pm and 5.5 pm, and the at least one perfluorocarbon compound has a boiling point above 100° C. The present description also relates to methods comprising administering such an injectable emulsion in, for example, ultrasound ablation surgery (FIG. 3).Type: GrantFiled: June 14, 2019Date of Patent: March 18, 2025Assignees: Avignon Université, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, Sorbonne Université, UNIVERSITE DE MONTPELLIER, ECOLE NATIONALE SUPERIEURE DE CHIMIE DE MONTPELLIERInventors: Christiane Contino-Pepin, Stéphane Desgranges, Nicolas Taulier
-
Patent number: 12251258Abstract: Disclosed is a method for characterising an object, comprising: emission of ultrasonic waves that enter an object by passing through an external interface, then reflect off an internal interface, then exit the object by passing through the external interface again, the ultrasonic waves comprising first waves having a mode that varies according to a first variation during their propagation in the object, and second waves having a mode that varies according to a second variation during their propagation in the object; reception of echo signals comprising first signals representing echoes of the first waves, and second signals representing echoes of the second waves, construction of a plurality of images showing the object, the plurality of images being constructed from the echo signals, under the assumption that two characteristics of the object are equal to two candidate values, and comprising a first image constructed from the first signals, and a second constructed from the second signals; construction of aType: GrantFiled: April 26, 2021Date of Patent: March 18, 2025Assignees: SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCE SCIENTIFIQUE (CNRS), INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEInventor: Guillaume Renaud
-
Patent number: 12248202Abstract: The invention relates to filter dedicated to protect eye cone cells and method associated. The eye cone cells protecting filter is intended to be applied to a transparent surface and to filter incident light for preventing eye cone cells of a user, from damages due to illumination at physiological light levels on the eye of said user, and having spectral characteristics to i) filter light wavelengths between 405 and 465 nanometers, and ii) transmit a filtered light reaching the eye cone cells and having a harmfulness on said eye cone cells under a predefined maximum threshold.Type: GrantFiled: March 13, 2020Date of Patent: March 11, 2025Assignees: Essilor International, Sorbonne UniversitéInventors: Mélanie Marie, Serge Picaud, Valérie Fradot, José Sahel, Thierry Villette, Coralie Barrau, Camille Ehrismann
-
Publication number: 20250040942Abstract: A medical device for penetrating an anatomic structure, e.g., a bone structure, including a processing unit programmed to execute one or more statistical algorithms, e.g., Bayesian-based perforation detection algorithms, with electrical conductivity measured during penetration of an anatomic structure as an input to detect a breach condition, e.g., a spinal canal perforation, based on the measured electrical conductivity. The medical device may include a drill bit having sensing capabilities coupled to the distal end of a robot arm via a power drill unit mounted on the robot arm. The power drill unit may cease transmission of rotary motion to the drill bit upon detection of the breach condition.Type: ApplicationFiled: July 25, 2024Publication date: February 6, 2025Applicants: SpineGuard, Sorbonne Universite, Centre National De La Recherche Scientifique-CNRS, INSERM (Institut National de la Sante et de la Recherche Medicale)Inventors: Lilyan LEBLANC, Brahim TAMADAZTE, Thibault CHANDANSON, Elie SAGHBINY
-
Patent number: 12215067Abstract: Disclosed is chemical compounds C that are derivatives of norbixin and have tropism for the eye, and are intended to be used in the treatment of eye diseases in mammals, in particular in the context of altering the retinal pigment epithelium and more particularly in the context of age-related macular degeneration (AMD) and Stargardt's disease.Type: GrantFiled: December 22, 2020Date of Patent: February 4, 2025Assignees: BIOPHYTIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), SORBONNE UNIVERSITEInventors: Laurence Dinan, René Lafont, Pierre Dilda, Serge Camelo, Valérie Fontaine, Christine Balducci, Elodie Monteiro, Louis Guibout, Mathilde Latil, José-Alain Sahel, Stanislas Veillet
-
Publication number: 20250029678Abstract: A computer-implemented method for determining and quantifying modes of activation of biological pathways in individual cells, including: receiving sequencing data obtained by a single-cell RNA sequencing method, and a plurality of gene lists, determining a gene-cell expression matrix based on the sequencing data and the plurality of gene lists, carrying out a principal component analysis (PCA) on said gene-cell expression matrix, so as to determine a plurality of modes of activation of at least one among the biological pathways, selecting a subset of so-called effective modes of activation among the plurality of modes of activation, determining a matrix referred to as activity matrix, the activity matrix including scores quantifying a level of activity of each effective mode of activation among the subset of effective modes of activation within each individual cell among the set of individual cells.Type: ApplicationFiled: July 20, 2023Publication date: January 23, 2025Applicants: One Biosciences, Centre National de la Recherche Scientifique, Institut CURIE, Sorbonne UniversitéInventors: Céline VALLOT, Yuna LANDAIS
-
Patent number: 12193443Abstract: The invention relates to the use, as a herbicide, of at least one compound chosen from the compounds of general formula (I) and organic or inorganic salts thereof and isomers thereof. The invention also relates to a phytotoxic composition and to a method for controlling the development of and/or treating undesirable plants on the surface of a target zone.Type: GrantFiled: March 16, 2020Date of Patent: January 14, 2025Assignees: ECOLE POLYTECHNIQUE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, SORBONNE UNIVERSITEInventors: Bastien Nay, Emmanuel Baudouin, Wei Zhang
-
Patent number: 12193864Abstract: The invention relates to a method for determining at least one property of an object, the method comprising a step of: a) obtaining first data relative to the object by an ultrasound imaging technique imaging the object at a frame rate superior to 300 Hz, characterized in that the method further comprises a step of: b) obtaining second data relative to the object by imaging the object with at least one of a X-ray and a ?-ray, and c) determining the at least one property of the object based on the first data and the second data.Type: GrantFiled: June 7, 2023Date of Patent: January 14, 2025Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, SORBONNE UNIVERSITE, UNIVERSITÉ PARIS CITÉ, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS, ASSISTANCE PUBLIQUE—HOPITAUX DE PARISInventors: Jean Provost, Anikitos Garofalakis, Mathieu Pernot, Mickaël Tanter, Bertrand Tavitian, Thomas Viel
-
Patent number: 12198573Abstract: A device for simulating a behavior of a mammal in an environment by a virtual mammal includes a mobile head and at least one mobile eye including a first input for successive data representative of eye poses, a second input for mobility action instructions, a memory for storing information on the environment and on stabilization constraints, at least one processor assessing a current part of the environment and recording information on said current part, triggering successive movements of the head and of the eye(s) in function of said mobility action, controlling a dynamic adjustment of the successive movements of the eye(s) with respect to the successive movements of the head in function of the successive data and by using the stabilization constraints. The device further comprises a third input for training data representative of a training movement sequence of the head and the eye(s) associated with a training environment.Type: GrantFiled: March 20, 2020Date of Patent: January 14, 2025Assignees: Essilor International, Sorbonne UniversitéInventors: Denis Sheynikhovich, Richard Carrillo, Luca Leonardo Bologna, Youssouf Cherifi, Tianyi Li, Angelo Arleo, Konogan Baranton, Anne-Catherine Scherlen, Delphine Tranvouez-Bernardin
-
Patent number: 12179192Abstract: Electroacoustic device having a transducer including a piezoelectric substrate, first and second electrodes of inverse polarity having respective first and second tracks provided on said substrate, the first and second tracks spiraling around a same center (C), the transducer being configured for generating a swirling ultrasonic surface wave in the substrate.Type: GrantFiled: June 16, 2023Date of Patent: December 31, 2024Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DE LILLE, ECOLE CENTRALE DE LILLE, SORBONNE UNIVERSITEInventors: Michaël Aymeric Baudoin, Olivier Khalil Nizar Bou Matar-Lacaze, Antoine Jean-Pierre Riaud, Jean-Louis Pierre Thomas
-
Patent number: 12181694Abstract: A Tamm electromagnetic cavity (10, 20, 30, 40, 60) possessing a resonant frequency in the THz domain, comprising: an interference mirror that is reflective in the THz domain, this mirror consisting of a stack of dielectric layers (7) comprising an alternation, in a z-direction, of two different layers, a layer referred to as the layer of high refractive index (2) and a layer referred to as the layer of low refractive index (4), the index of the layer of low refraction being lower than that of the layer of high refractive index, and being manufactured by stacking layers mechanically or by joining dielectric layers to one another; an upper metal layer (5) deposited on or added to an upper dielectric layer of said interference mirror so as to form a structure that supports at least one Tamm mode in the THz domain, the upper metal layer (5) being structured so as to form an antenna possessing a resonant frequency equal to that of the electromagnetic cavity.Type: GrantFiled: April 3, 2020Date of Patent: December 31, 2024Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE CLAUDE BERNARD LYON 1, SORBONNE UNIVERSITE, ECOLE NORMALE SUPERIEURE DE PARIS, UNIVERSITE DE PARISInventors: Juliette Mangeney, Sukhdeep Dhillon, Clémentine Symonds, Joël Bellessa, Simon Messelot
-
Patent number: 12175663Abstract: The present invention concerns a device for producing a “digital video classifier” configured to determine the quality of cleanliness of one or more segments of the digestive tube in a video capsule endoscopy (VCE) of a subject, comprising: a VCE allowing the acquisition of videos of segments of the digestive tube, video storage means, coupled with the VCE, an “image database” with images extracted from VCE exams, a “video database” with videos extracted from VCE exams, calculating means connected to the video storage means, and to the databases, and configured for performing a statistical learning for the generation of a “digital image classifier” from the “image database” and which classifies the images in adequate cleanliness or non-adequate cleanliness; generating the “digital video classifier” capable of classifying a video of a subject as being of adequate cleanliness or of non-adequate cleanliness of one or more segments of the digestive tube.Type: GrantFiled: September 28, 2021Date of Patent: December 24, 2024Assignees: ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ÉCOLE NATIONALE SUPÉRIEURE DE L'ELECTRONIQUE ET DE SES APPLICATIONS, CY CERGY PARIS UNIVERSITEInventors: Marc Souchaud, Aymeric Histace, Romain Leenhardt, Xavier Dray
-
Patent number: 12173053Abstract: The invention is in the field of therapy of antibody deficiencies. Inventors demonstrate for the first time in both controls and IgA-deficient patients. systemic anti-microbiota IgG responses correlate with reduced inflammation suggesting that systemic IgG responses contribute to the gut microbiota confinement. Furthermore. SIgAd-associated inflammation is inversely correlated with systemic anti-commensal IgG responses, which may thus serve as a second line of defense. Altogether, these data suggest that systemic IgG and intestinal IgA cooperate in different body compartments to limit systemic pro-inflammatory pathways. As selective IgA deficient patients harbour elevated seric anti-commensal IgG levels. these findings suggest that in selective IgA deficiency, microbiota confinement is obtained at the price of a strong inflammatory response. Accordingly. the invention relates to a composition containing immunoglobulins A (IgA). more particularly secretory IgA.Type: GrantFiled: June 19, 2023Date of Patent: December 24, 2024Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP)Inventors: Guy Gorochov, Martin Larsen, Delphine Sterlin, Jehane Fadlallah